hit counter

Mirapex (Pramipexole) For Depression: An Effective Antidepressant?

Mirapex (Pramipexole) is a drug that is approved by the FDA for the treatment of Parkinson’s disease and RLS (restless leg syndrome).  Classified as a dopamine receptor agonist, pramipexole elicits partial or full agonism upon D3 receptors, D2 receptors (2L/2S), and D4 receptors.  Interestingly, pramipexole also appears to modify mitochondrial function, and to a negligible …

Read more

Mirapex (Pramipexole) Side Effects & Adverse Reactions (List)

Mirapex (Pramipexole) is a medication that was approved by the FDA in 1997 for the treatment of idiopathic (early-stage and advanced) Parkinson’s disease.  Analysis of the drug’s pharmacodynamics reveals its function as a mixed partial/full dopamine agonist, with highest affinity for: D3 receptors, D2 receptors (D2S and D2L), and D4 receptors (in that order).  To …

Read more

Namenda (Memantine) Side Effects & Adverse Reactions

Namenda (Memantine) is a drug that was approved by the FDA in 2003 for the treatment of Alzheimer’s disease.  Research suggests that Namenda has a small effect in reducing symptoms among those diagnosed with moderate or severe cases of Alzheimer’s.  It appears to have no significant effect when administered to individuals diagnosed with milder cases …

Read more

Dementia Linked To Benzodiazepines, Sleeping Pills, Anticholinergics

In recent years, increasing evidence has suggested that certain types of commonly prescribed medications may cause increased risk of developing dementia. This ranges from drugs used to treat anxiety (e.g. Xanax) to over-the-counter drugs (e.g. Benadryl). A majority of these medications tend to depress activity in the CNS and help minimize arousal and/or anxiety. Dementia …

Read more